Management of nonpregnant women with elevated human chorionic gonadotropin
- PMID: 24251053
- PMCID: PMC3819893
- DOI: 10.1155/2013/580709
Management of nonpregnant women with elevated human chorionic gonadotropin
Abstract
Human chorionic gonadotropin (hCG) is useful in evaluating and monitoring early pregnancy as well as trophoblastic disease. Here we describe the management of women with elevated serum human chorionic gonadotropin in a case of a 51-year-old female who was unsuccessfully treated for ectopic pregnancy. She was subsequently diagnosed with pituitary hCG production, which should be considered as differential diagnosis before treatment is initiated.
Figures
References
-
- Penzias AS, Huang P-L. Imaging in ectopic pregnancy. Journal of Reproductive Medicine for the Obstetrician and Gynecologist. 1992;37(1):47–53. - PubMed
-
- Cole LA. Phantom hCG and phantom choriocarcinoma. Gynecologic Oncology. 1998;71(2):325–329. - PubMed
-
- Cao Z, Rej R. Are laboratories reporting serum quantitative hCG results correctly? Clinical Chemistry. 2008;54(4):761–764. - PubMed
-
- Jiménez-Caraballo A, Rodríguez-Donoso G. A 6-year clinical trial of methotrexate therapy in the treatment of ectopic pregnancy. European Journal of Obstetrics Gynecology and Reproductive Biology. 1998;79(2):167–171. - PubMed
-
- Birken S, Maydelman Y, Gawinowicz MA, Pound A, Liu Y, Hartree AS. Isolation and characterization of human pituitary chorionic gonadotropin. Endocrinology. 1996;137(4):1402–1411. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
